FDA.reportPublic FDA data

Application 079111

Type
ANDA
Sponsor
AUROBINDO PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIBAVIRINRIBAVIRINTABLET;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65862-207RibavirinRibavirinAurobindo Pharma LimitedANDACurrent
65862-207RibavirinRibavirinAurobindo Pharma LimitedANDACurrent
65862-207RibavirinRibavirinAurobindo Pharma LimitedANDACurrent
65862-207RibavirinRibavirinAurobindo Pharma LimitedANDACurrent
65862-207RibavirinRibavirinAurobindo Pharma LimitedANDACurrent